DSCC1: A Potential Drug Target and Biomarker for Defective in Sister Chromatid Cohesion 1 Homolog

Target Name: DSCC1

NCBI ID: G79075

DSCC1

DSCC1: A Potential Drug Target and Biomarker for Defective in Sister Chromatid Cohesion 1 Homolog

Sister chromatid cohesion 1 (SCC1) is a gene that plays a crucial role in the development and maintenance of normal sister chromatid cohesion (SCC) in the human genome. SCC is a critical aspect of chromosome structure and function, as it helps ensure the stability and integrity of chromosomes during various cell cycle stages. The SCC1 gene is one of the key components of the SCC system and has been implicated in various genetic and epigenetic processes, including cancer, neurodegenerative diseases, and developmental disorders.

DSCC1, the defective in sister chromatid cohesion 1 homolog, is a variant of the SCC1 gene that has been identified as a gene mutant in many diseases, including neurodevelopmental and psychiatric disorders. The DSCC1 gene has been shown to be involved in the development and progression of various diseases, including neurodegenerative disorders, cancer, and cardiovascular diseases.

DSCC1 as a Drug Target

DSCC1 has been identified as a potential drug target due to its involvement in various diseases. The DSCC1 gene has been shown to be involved in the development and progression of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. These disorders are characterized by the progressive loss of brain cells and the accumulation of neurofibrillary tangles and other aberrations in the brain.

DSCC1 has also been linked to the development and progression of various cancers, including breast, ovarian, and prostate cancers. The DSCC1 gene has been shown to be involved in the regulation of cell growth, apoptosis, and angiogenesis, which are all critical processes that are altered in cancer cells.

DSCC1 as a Biomarker

DSCC1 has also been identified as a potential biomarker for various diseases, including neurodegenerative disorders, cancer, and cardiovascular diseases. The DSCC1 gene has been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and survival.

DSCC1 has been shown to be involved in the regulation of tight junctions, which are a type of cell-cell adhesion that helps maintain the integrity of tissues and is critical for various physiological processes, including cell signaling and barrier function. The tight junction is also involved in the regulation of ion and solute transport, as well as the maintenance of cellular homeostasis.

DSCC1 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. The DSCC1 gene has been shown to be involved in the regulation of angiogenesis, including the formation of blood-brain barriers and the regulation of vascular sprouting.

Conclusion

DSCC1 is a gene that has been implicated in various diseases, including neurodegenerative disorders, cancer, and cardiovascular diseases. The DSCC1 gene has been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and survival.

DSCC1 has also been identified as a potential drug target due to its involvement in the development and progression of neurodegenerative disorders and various cancers. The DSCC1 gene has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

Future studies are needed to further investigate the role of DSCC1 in various diseases and to develop effective treatments based on its potential as a drug target and biomarker.

Protein Name: DNA Replication And Sister Chromatid Cohesion 1

Functions: Loads PCNA onto primed templates regulating velocity, spacing and restart activity of replication forks. May couple DNA replication to sister chromatid cohesion through regulation of the acetylation of the cohesin subunit SMC3

The "DSCC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DSCC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets